MASSIRONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.603
EU - Europa 1.246
AS - Asia 674
SA - Sud America 79
AF - Africa 8
OC - Oceania 4
Totale 3.614
Nazione #
US - Stati Uniti d'America 1.586
IT - Italia 311
RU - Federazione Russa 296
SG - Singapore 294
DE - Germania 190
IE - Irlanda 179
HK - Hong Kong 157
SE - Svezia 132
CN - Cina 123
BR - Brasile 72
GB - Regno Unito 34
ID - Indonesia 30
AT - Austria 16
UA - Ucraina 16
FI - Finlandia 14
FR - Francia 14
IN - India 13
NL - Olanda 13
PH - Filippine 12
CA - Canada 11
BE - Belgio 8
VN - Vietnam 6
CZ - Repubblica Ceca 5
TW - Taiwan 5
AU - Australia 4
MM - Myanmar 4
MX - Messico 4
MY - Malesia 4
TR - Turchia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
PK - Pakistan 3
BG - Bulgaria 2
DK - Danimarca 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
PL - Polonia 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BJ - Benin 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
TJ - Tagikistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.614
Città #
Ann Arbor 510
Singapore 227
Dublin 173
Hong Kong 157
Frankfurt am Main 139
Chandler 118
Milan 102
Ashburn 71
Fairfield 67
Wilmington 62
Santa Clara 54
New York 52
Shanghai 51
Princeton 41
Houston 33
Woodbridge 32
Jakarta 29
Chicago 24
Seattle 24
London 23
Los Angeles 23
Cambridge 22
Moscow 21
Beijing 20
Lawrence 20
Florence 18
Altamura 17
San Diego 17
Hangzhou 14
Nuremberg 13
Rome 13
Helsinki 11
Guangzhou 10
Bari 8
Davao City 8
Munich 8
Boardman 7
Desio 7
Garbagnate Milanese 7
São Paulo 7
Toronto 7
Vienna 7
Falls Church 6
Pune 6
Brno 5
Comazzo 5
Dearborn 5
Dong Ket 5
Düsseldorf 5
Romola 5
Andover 4
Antwerp 4
Bologna 4
Butuan 4
Fremont 4
Genoa 4
Jinan 4
Monza 4
Rio de Janeiro 4
Tashkent 4
Antibes 3
Belo Horizonte 3
Bergamo 3
Brussels 3
Cinisello Balsamo 3
Council Bluffs 3
Hyderabad 3
Jacksonville 3
Kilburn 3
Kuala Lumpur 3
Lauterbourg 3
Modena 3
Naples 3
New Taipei 3
Sydney 3
Vicenza 3
Vigevano 3
Arese 2
Atlanta 2
Bellinzago Novarese 2
Bonndorf 2
Brasília 2
Bushey 2
Cairo 2
Casatenovo 2
Changsha 2
Dallas 2
Dubai 2
Esslingen am Neckar 2
Federal Way 2
Groningen 2
Guayaquil 2
Islamabad 2
Istanbul 2
Lappeenranta 2
Lecce 2
Meda 2
Medina 2
Mexico City 2
Mumbai 2
Totale 2.453
Nome #
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 218
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 215
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 213
Understanding short bowel syndrome: Current status and future perspectives 201
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 194
High rates of 30-day mortality in patients with cirrhosis and COVID-19 185
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 146
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 142
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 141
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 101
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 97
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 91
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 91
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 87
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 80
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 76
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 72
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 72
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 70
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 69
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 69
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 66
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 64
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 63
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 62
Eosinophilic esophagitis: does age matter? 56
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 56
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 55
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 55
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 55
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 55
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 49
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 48
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 46
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 45
Systematic review-Pancreatic involvement in inflammatory bowel disease 43
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 39
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 36
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 34
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 31
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 31
Totale 3.792
Categoria #
all - tutte 19.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 0 0 0 23 14 5
2020/2021568 26 8 45 34 67 70 63 70 47 47 44 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.411 90 164 157 77 148 99 137 57 152 330 0 0
Totale 3.792